BREAKING: Target Test Prep releases Brand New 2026 On Demand GMAT prep course

Redeem

Target Test Prep · GMAT

Choose how you want to prepare

Learn live with an expert or move at your own pace. Every option includes the complete TTP study system.

★★★★★5.0559 reviews
Vote for Target Test Prep, Newsweek Readers’ Choice Awards 2026
NEWSWEEK READERS’ CHOICE 2026

BIG NEWS! Target Test Prep has been nominated, and they’d love your vote!

TTP has worked incredibly hard to build the best test prep experience possible, and winning Newsweek’s 2026 Readers’ Choice Award for Best Test Prep would mean a lot to them. If TTP has helped you, they’d be incredibly grateful for your vote. You can vote once each day through September 9.

Vote for TTP
GMATLiveTeach 7 seats left
Chris Peckover
NEXT LIVE COHORT

Oct 13 to Jan 7, 2027

with Chris Peckover

Schedule
Tue, Thu · 8:00 to 10:00 PM ET
Included
40 live hours + 6 months of GMAT OnDemand
  • Live instruction and real-time questions
  • Class recordings and assigned practice
View class & enroll
Limited cohort · enrollment openTarget Test Prep
EALiveTeach 5 seats left
Logan Thompson
EXECUTIVE ASSESSMENT

Sep 6 to Dec 6, 2026

with Logan Thompson

Schedule
Sun · 9:30 AM to 12:30 PM ET
Included
40 hours of live online classes plus six months of access to the complete TTP EA OnDemand course.
  • 165+ EA Score Guarantee
  • 4,100+ Quant, Verbal, and Integrated Reasoning practice questions
  • 400+ hours of in-depth video lessons
  • 3,000+ step-by-step video solutions
View EA class & enroll
Limited cohort · enrollment openTarget Test Prep
GMATOnDemand Start anytime
SELF-PACED MASTERCLASS

Target Test Prep GMAT OnDemand

Complete access from day one. Study on your schedule.

715+ score guarantee
$0to start then $127/mo
  • Personalized study plan and analytics
  • Thousands of lessons and practice questions

Compare the format, schedule, and included access before enrolling. Prices and seat counts shown reflect the supplied offer details.

BOLDFACE

Expert replies
by KSHITIJ205 » Wed Jul 29, 2015 7:43 am
Public health advocate: It is generally true that medications that undergo the extensive FDA Phase III clinical safety testing are much safer than less-researched drugs. It is also true that whenever such trials are conducted, fewer people have experienced unexpected harmful side effects, thus reducing public health risks. However, eliminating the requirement that even FDA-tested medications continue to include extensive warnings about individual risk factors would almost certainly harm rather than help public health. Consumers would tend to rely on the FDA's general certification of safety, and if no longer encouraged to read about individual risks and drug interactions, many patients would suffer serious adverse reactions.

The two bolded statements serve what purpose in the context of the public health advocate's argument?

A The first is a general pattern that the advocate accepts as true; the second is said to be a natural consequence that must follow if the general pattern applies.

B The first is a causal relationship that the advocate believes will happen again in the case at issue; the second admits a situation in which the relationship
would not hold.

C The first describes a cause and effect relationship that the advocate believes will not hold in the case at issue;
the second suggests a consideration that supports that belief.

D The first is proof that the advocate uses to support a prediction; the second states that prediction.

E The first acknowledges a consideration that weighs against the stance that the advocate supports; the second is that stance.
OA C
Join the discussion
Source: — Critical Reasoning |

by MartyMurray » Thu Jul 30, 2015 4:58 pm
KSHITIJ205 wrote:Public health advocate: It is generally true that medications that undergo the extensive FDA Phase III clinical safety testing are much safer than less-researched drugs. It is also true that whenever such trials are conducted, fewer people have experienced unexpected harmful side effects, thus reducing public health risks. However, eliminating the requirement that even FDA-tested medications continue to include extensive warnings about individual risk factors would almost certainly harm rather than help public health. Consumers would tend to rely on the FDA's general certification of safety, and if no longer encouraged to read about individual risks and drug interactions, many patients would suffer serious adverse reactions.

The two bolded statements serve what purpose in the context of the public health advocate's argument?

A The first is a general pattern that the advocate accepts as true; the second is said to be a natural consequence that must follow if the general pattern applies.

B The first is a causal relationship that the advocate believes will happen again in the case at issue; the second admits a situation in which the relationship
would not hold.

C The first describes a cause and effect relationship that the advocate believes will not hold in the case at issue;
the second suggests a consideration that supports that belief.

D The first is proof that the advocate uses to support a prediction; the second states that prediction.

E The first acknowledges a consideration that weighs against the stance that the advocate supports; the second is that stance.
OA C
Generally to get the right answer to a boldfaced CR question, one can simplify things by eliminating the obviously wrong answers. Then with maybe two answers left, one can figure out which is better.

Eliminating some answers can be pretty easy as generally one or both of the descriptions they contain clearly do not match the boldfaced portions.

Choice A for, for instance, can be quickly eliminated, because the description of the second boldfaced portion is clearly wrong. The second part is clearly not a consequence what's described in the first.

Choice B, can also be eliminated pretty easily. The choice is a little tempting at first, but then you realize that the two descriptions contradict each other. The author cannot both believe that the relationship will hold in the case described and admit that it will not.

C is interesting. Maybe the descriptions make sense. I am not sure that I really like C, but ok the author is saying that in a situation without labeling public health will be harmed. So I guess maybe he is saying that the usual cause and effect of FDA trials creating safety will not hold, and the second portion could be seen to be supporting that. Let's see if there is anything better though.

Choice D is easily eliminated. The first in no way supports the second. So now we have eliminated three out of five answer choices and there are only two left to worry about. So that's good.

E is tempting too. Hmm. The first does seem to weigh against the prediction, maybe, but maybe not, and then the second might be the stance of the author. However, looking back up, I found the actual stance, i.e. the conclusion. It's this, "eliminating the requirement that even FDA-tested medications continue to include extensive warnings about individual risk factors would almost certainly harm rather than help public health." So the second boldfaced portion is not the stance, it's more something that supports that stance. So that makes C look better for the second portion.

Is C the winner? We could check the first part to make sure.

I guess the first part of C is closer to what's going on than is the first part of E. I am not sure I really like the wording of C, as I don't really see a "case", though I do see an issue, but E is even worse as the first boldfaced portion does not really weigh against the thesis that lack of labeling harms public health.

So having whittled it down to two answers and having weighed the validity of those two, considering all the angles, we can choose C.
Marty Murray
Perfect Scoring Tutor With Over a Decade of Experience
MartyMurrayCoaching.com
Contact me at [email protected] for a free consultation.
Join the discussion

by KSHITIJ205 » Thu Jul 30, 2015 7:20 pm
thank you, i was a little confused between E and C.. got it now. APOLOGIES for not having highlighted the boldface sections..
Join the discussion